Jul 22, 2025 / 11:00AM GMT
Operator
Ladies and gentlemen, welcome to the Sartorius and Sartorius Stedim Biotech H1 2025 conference call and live webcast. I'm Matilda, the chorus call operator. (Operator Instructions) And the conference is being recorded. This call is scheduled for 60 minutes. The presentation will be followed by a Q&A session.
(Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to Michael Grosse, CEO. Please go ahead.
Michael Grosse - Sartorius AG - Chief Executive Officer, Member of the Executive Board
Thank you, Matilda, and good afternoon, everyone, and thank you for joining today's call on our H1 results of the Sartorius AG as well as Sartorius Stedim Biotech. Today, I'm together with Florian Funck, our CFO, with Rene Faber, our Head of Bioprocessing division and CEO of Sartorius Stedim Biotech; and also Alexandra Gatzemeyer, our Head of the Lab division.
But before I walk you through our financials and the full year outlook of the Sartorius AG, I would like to
Q2 2025 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript
1 day ago
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers